By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development and manufacturing of genetic medicines81.39M100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United Kingdom81.39M100.00%